Prescription drug abuse in USA "poses public health threat"

10 May 2009

A national alliance of families, the pharmaceutical industry, patients, consumer groups, and drug abuse prevention advocates in the USA has  released a nation-wide strategy proposal to counter the continued rise  in prescription drug abuse.

"Rising rates of prescription drug abuse are the result of a combination  of factors and can only be countered successfully by a coordinated,  multi-sector strategy," said Michael Barnes, executive director of  CLAAD, the Center for Lawful Access and Abuse Deterrence. The CLAAD's  National Prescription Drug Abuse Strategy, co-written with the Human  Resources Development Institute, advocates a balanced public policy  approach.

Abuse second only to marijuana

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight